Anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: Comparison of Age-related Macular Degeneration Treatments Trials 5year outcomes and implication for clinical practice

Chong Elaine W.; Al-Qureshi Salmaan H.

首页> 外文期刊>Clinical and experimental ophthalmology >Anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: Comparison of Age-related Macular Degeneration Treatments Trials 5year outcomes and implication for clinical practice

【24h】

Anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: Comparison of Age-related Macular Degeneration Treatments Trials 5year outcomes and implication for clinical practice

机译：抗血管内皮生长因子治疗用于新生血管年龄相关的黄斑变性：年龄相关黄斑变性治疗的比较试验5EEAR结果和临床实践的含义

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical and experimental ophthalmology》 |2017年第4期|共3页
作者
Chong Elaine W.; Al-Qureshi Salmaan H.;
展开▼
作者单位

Royal Victorian Eye &

Ear Hosp Melbourne Vic Australia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: Comparison of Age-related Macular Degeneration Treatments Trials 5year outcomes and implication for clinical practice [J] . Chong Elaine W., Al-Qureshi Salmaan H. Clinical and experimental ophthalmology . 2017,第4期

机译：抗血管内皮生长因子治疗用于新生血管年龄相关的黄斑变性：年龄相关黄斑变性治疗的比较试验5EEAR结果和临床实践的含义
2. Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761) Reply [J] . Maguire Maureen G. Ophthalmology . 2017,第3期

机译：Re：年龄相关黄斑变性治疗的比较试验（CATT）研究组，等人：抗血管内皮生长因子治疗新生血管年龄相关性黄斑变性的五年结果：年龄相关黄斑变性治疗的比较试验（2016年眼科; 123：1751-1761）回复
3. Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration The Comparison of Age-Related Macular Degeneration Treatments Trials [J] . Maguire Maureen G., Martin Daniel F., Ying Gui-shuang, Ophthalmology . 2016,第8期

机译：抗血管内皮生长因子治疗新血管性年龄相关性黄斑变性的五年结局与年龄相关性黄斑变性治疗试验的比较
4. Bevacizumab (Avastin) conjugated microbubbles for anti-VEGF treatment of neovascular age-related macular degeneration [C] . Leilei Zhang, Jeff Xu, Jiwei Huang, Conference on ophthalmic technologies . 2010

机译：贝伐单抗（Avastin）缀合的微泡用于抗VEGF治疗新生血管性年龄相关性黄斑变性
5. Arterial Thromboembolic Events following Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy for Age-Related Macular Degeneration in Regular Clinical Practice. [D] . Fafowora, Oluwatoyin Folasade. 2015

机译：在常规临床实践中，玻璃体内血管内皮生长因子抑制剂治疗与年龄相关的黄斑变性的动脉血栓栓塞事件。
6. Influence of vitreomacular interface on anti-vascular endothelial growth factor treatment outcomes in neovascular age-related macular degeneration [O] . Meng Gao, LiMei Liu, XiDa Liang, -1

机译：玻璃体界面对新生血管性年龄相关性黄斑变性中抗血管内皮生长因子治疗结果的影响
7. Five-year outcomes of a personalized pro re nata treatment regimen with anti-vascular endothelial growth factor for neovascular age-related macular degeneration [O] . Martin Stattin, Julia Forster, Alexandra Graf, 2018

机译：个性化Pro的五年成果，Nata治疗方案具有抗血管内皮生长因子的新生血管年龄相关性黄斑变性

Anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: Comparison of Age-related Macular Degeneration Treatments Trials 5year outcomes and implication for clinical practice

著录项

相似文献

相关主题

期刊订阅